Oncolytics Biotech IncGewinn- und Verlustrechnung
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 0.8122 USD | 1,51 USD | 0,77 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 5,052 USD | 1 | 4 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 119.354.067 | 5,65 | 4,17 |
Kennzahl in 1000 USD | TTM 2007-09-30 | 2012-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2000-12-31 | 1999-12-31 |
|---|---|---|---|---|---|---|---|---|
Umsatz | - | - | - | - | - | - | - | - |
Herstellungskosten | - | - | - | - | - | - | - | - |
Bruttoergebnis | - | - | - | - | - | - | - | - |
▸ Brutto-Marge | -% | -% | -% | -% | -% | -% | -% | -% |
Betriebliche Aufwendungen | - | - | - | - | - | - | - | - |
Operativer Gewinn/Verlust | - | - | - | - | - | - | - | - |
▸ Operative Marge | -% | -% | -% | -% | -% | -% | -% | -% |
Zinsen (Netto) | - | - | - | - | - | - | - | - |
▸ Zinsausgaben | - | - | - | - | - | - | - | - |
▸ Zinseinnahmen | - | - | - | - | - | - | - | - |
Andere Ausgaben | - | - | - | - | - | - | - | - |
Gewinn vor Steuern | - | - | - | - | - | - | - | - |
Steueraufwand | - | - | - | - | - | - | - | - |
Minderheitenanteil | - | - | - | - | - | - | - | - |
Nettogewinn/-verlust | - | - | - | - | - | - | - | - |
▸ Netto-Marge | -% | -% | -% | -% | -% | -% | -% | -% |